Quoin Pharmaceuticals, Ltd. (QNRX)
QNRX Stock Price Chart
Explore Quoin Pharmaceuticals, Ltd. interactive price chart. Choose custom timeframes to analyze QNRX price movements and trends.
QNRX Company Profile
Discover essential business fundamentals and corporate details for Quoin Pharmaceuticals, Ltd. (QNRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Aug 2016
Employees
3.00
Website
https://quoinpharma.comCEO
Michael Myers
Description
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.
QNRX Financial Timeline
Browse a chronological timeline of Quoin Pharmaceuticals, Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$1.61.
Earnings released on 7 May 2026
EPS came in at -$1.77 surpassing the estimated -$1.80 by +1.67%.
Earnings released on 26 Mar 2026
EPS came in at -$14.80 falling short of the estimated -$6.42 by -130.53%.
Earnings released on 6 Nov 2025
EPS came in at -$6.71 falling short of the estimated -$6.36 by -5.50%.
Earnings released on 7 Aug 2025
EPS came in at -$6.28 surpassing the estimated -$6.83 by +8.05%.
Earnings released on 13 May 2025
EPS came in at -$6.50 falling short of the estimated -$3.85 by -68.83%.
Earnings released on 13 Mar 2025
EPS came in at -$12.24 falling short of the estimated -$0.50 by -2.35k%.
Earnings released on 7 Nov 2024
EPS came in at -$16.43 falling short of the estimated -$15.38 by -6.83%.
Earnings released on 8 Aug 2024
EPS came in at -$13.64 surpassing the estimated -$26.22 by +47.98%.
Earnings released on 9 May 2024
EPS came in at -$38.81 falling short of the estimated -$0.76 by -5.01k%.
Earnings released on 13 Mar 2024
EPS came in at -$72.73 surpassing the estimated -$82.87 by +12.24%, while revenue for the quarter reached $154.77k .
Earnings released on 8 Nov 2023
EPS came in at -$68.18 surpassing the estimated -$83.92 by +18.76%.
Earnings released on 2 Aug 2023
EPS came in at -$74.48 falling short of the estimated -$2.82 by -2.54k%.
Stock split effective on 18 Jul 2023
Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 May 2023
EPS came in at -$142.71 falling short of the estimated -$109.13 by -30.77%.
Earnings released on 8 Mar 2023
EPS came in at -$172.10 falling short of the estimated $0.62 by -27.86k%.
Earnings released on 10 Nov 2022
EPS came in at -$394.56 surpassing the estimated -$1.22k by +67.59%.
Earnings released on 18 Aug 2022
EPS came in at -$13.60 falling short of the estimated -$3.08 by -341.56%.
Stock split effective on 1 Aug 2022
Shares were split 2 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Apr 2022
EPS came in at -$21.27 falling short of the estimated -$8.81 by -141.45%.
Earnings released on 31 Dec 2021
EPS came in at -$949.32 .
Earnings released on 17 Dec 2021
EPS came in at -$70.11 falling short of the estimated -$3.25 by -2.06k%.
Stock split effective on 24 Sept 2021
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 24 Aug 2021
EPS came in at -$216.57 .
QNRX Stock Performance
Access detailed QNRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
